 |
Prof Li Xiaorong MD PhD
Senior Consultant |
| Department |
Surgical Retina |
| Languages |
Chinese & English |
| Conditions treated |
Complicated retinal diseases, the early detection and novel treatment for retinal detachment and diabetic retinopathy |
| Procedures performed |
Refractive cataract surgery, laser treatment for diabetic retinopathy |
| Research interests |
Innovative approach for retinal procedure, stem cell treatment for retinal diseases |
|
 |
| Prof. Li Xiao-Rong is an experienced vitreo-retinal surgeon and an ophthalmological professor who is enthusiastic in the innovative approaches for retinal diseases. He is the Director of Tianjin Medical University Eye Hospital, the School of Optometry and Ophthalmology, and Tianjin Medical University Eye Institute. He is a government special allowance expert, Tianjin model worker, Tianjin outstanding Communist Party member, and Trans-century talent of Tianjin Medical University. |
| Education and training |
|
| |
PhD |
Tianjin Medical University |
| 1998-1999 |
International clinical fellow |
Singapore National Eye Center |
| |
|
| Professional memberships |
Expert member of the ophthalmic branch |
| |
|
Committee member of the ocular fundus disease group |
| |
|
Standing committee member of the Ophthalmologist branch of the Chinese Medical Association |
| |
|
Vice chairman of the ophthalmic branch of Tianjin Medical Association |
| |
|
Senior clinical scientist of Singapore Eye Research Institute |
| |
|
Vice chairman of the China Association for the promotion of international health care exchange |
| |
|
Consultant for the Cross Straits Medical and Health Exchange Association ophthalmic committee maculopathy group |
| Editorial Roles |
|
Chinese Journal of Ophthalmology, Chinese Journal of Ocular Fundus Disease, Chinese Journal of Experimental Ophthalmology, Chinese Journal of Occupational Ophthalmopathy, Recent Advances in Ophthalmology, Chinese Journal of Optometry and Visual Science, and International Review of Ophthalmology and Retina (Chinese version). |
| Awards & Honors |
|
Third prize of the Chinese Medical Science Prize |
| |
|
Second and third prizes of the Tianjin Science and Technology Progress Award, |
| Selected publications |
|
| 2019 |
Diabetes |
A Protective Effect of PPARα in Endothelial Progenitor Cells Through Regulating Metabolism. Shao Y, Chen J, Dong LJ, He X, Cheng R, Zhou K, Liu J, Qiu F, Li XR, Ma JX. |
| |
|
| 2019 |
Stem Cells |
Canonical Wnt Signaling Promotes Neovascularization Through Determination of Endothelial Progenitor Cell Fate via Metabolic Profile Regulation. Shao Y, Chen J, Freeman W, Dong LJ, Zhang ZH, Xu M, Qiu F, Du Y, Liu J, Li XR, Ma JX. |
| |
|
| 2019 |
Int J Ophthalmol. |
Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis. Yang QH, Zhang Y, Zhang XM, Li XR. |
| |
|
| 2019 |
Clin Exp Ophthalmol. |
Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion-related macular oedema: A prospective randomized comparison-Comment. Wen D, Li XR, He Y, Ren X, Zheng C |
| |
|
| 2018 |
Int J Ophthalmol. |
Protective effects of a novel drug RC28-E blocking both VEGF and FGF2 on early diabetic rat retina. Yang QH, Zhang Y, Jiang J, Wu MM, Han Q, Bo QY, Yu GW, Ru YS, Liu X, Huang M, Wang L, Zhang XM, Fang JM, Li XR. |
| |
|
| 2014 |
Retina |
Idiopathic epiretinal membrane. Bu SC, Kuijer R, Li XR, Hooymans JM, Los LI. |
|
|
